In these resistant cells, key KMT2A target genes, such as MEIS1 and HOXA, remain suppressed, and although the menin–KMT2A complex is successfully displaced from chromatin by the inhibitors, leukemia persists. This evidence concerns the gene KMT2A and leukemia.